IDiyas

For the Inventor, By the Inventor

Marburg, Germany

Michael Kraus

USPTO Granted Patents = 16

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 81(Granted Patents)


Company Filing History:

goldMedal10 out of 149 
 
Dade Behring Marburg Gmbh
 patents
silverMedal4 out of 340 
 
Behringwerke Aktiengesellschaft
 patents
bronzeMedal2 out of 39 
 
Behring Diagnostics Gmbh
 patents

Years Active: 1994-2004

Loading Chart...
16 patents (USPTO):Explore Patents
1. 6750032 - Method and diagnostic agent for hemostasis diagnosis (2004-06-15),
2. 6632599 - Detection and determination of solid phase-associated factors (2003-10-14),
3. 6482653 - Method and diagnostic agent for hemostasis diagnosis (2002-11-19),
4. 6441141 - Synthetic peptides, antibodies against them and their use (2002-08-27),
5. 6376209 - Increasing the FVII sensitivity of a thromboplastin reagent (2002-04-23),
6. 6211344 - Process for preparing factor V-deficient plasma, and a deficient plasma which is obtained in this way (2001-04-03),
7. 6194214 - Use of annexins as a lupus anticoagulant control or standard in clotting tests (2001-02-27),
8. 6187594 - Method and diagnostic agent for hemostasis diagnosis (2001-02-13),
9. 6143575 - Heterogeneous immunoassay using a precipitable solid phase (2000-11-07),
10. 6090570 - Method for specifically detecting a coagulation factor V which has an (2000-07-18),
11. 5981697 - Synthetic peptides, antibodies against them and their use (1999-11-09),
12. 5753510 - Calibrator for use in test methods for detecting a defective coagulation (1998-05-19),
13. 5726028 - Method for detecting disturbances of the protein c/protein s system (1998-03-10),
14. 5599678 - Antibodies which react with fibrinogen fragments E1, E2 and E3 and (1997-02-04),
15. 5571728 - Method for analyzing particle-enhanced agglutination reactions in (1996-11-05),

Title: Innovations by Inventor Michael Kraus

Introduction

Michael Kraus is a renowned inventor based in Marburg, Germany, known for his contributions to the field of hemostasis and diagnostics. With a portfolio of 16 patents, Kraus has made significant strides towards improving diagnostic methodologies and enhancing the efficiency of medical procedures.

Latest Patents

Among his latest patents is a "Method and diagnostic agent for hemostasis diagnosis," which focuses on detecting hemostasis disturbances through blood platelet interactions. The invention provides a way to measure interactions between substances that play crucial roles in clot formation and dissolution.

Another notable patent is the "Detection and determination of solid phase-associated factors." This invention outlines a procedure for detecting solid phase-associated factors that are linked to the same solid phase. By utilizing transmitter and receiver particles with specific ligands, this method allows for the identification of cell surface receptors, presenting a streamlined alternative to conventional flow cytometry.

Career Highlights

Michael Kraus has worked with prominent companies in the medical field, including Dade Behring GmbH and Behringwerke Aktiengesellschaft. His experience in these organizations has solidified his position as a leading inventor in diagnostic technology.

Collaborations

During his career, Kraus has collaborated with notable colleagues such as Carsten Schelp and Andreas Wiegand. These partnerships have fostered an environment of innovation and have led to the development of groundbreaking technologies in diagnostics.

Conclusion

Michael Kraus continues to be an influential figure in the realm of medical diagnostics, with his inventions paving the way for more accurate and efficient testing methods. His ongoing contributions are expected to have a lasting impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…